Matsudo, Japan

Ryuichi Yokohari



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryuichi Yokohari: Innovator in Autoantibody Removal Technology

Introduction

Ryuichi Yokohari is a notable inventor based in Japan, recognized for his contributions to the field of medical technology. His innovative work focuses on the development of an autoantibody adsorbent and apparatus designed to selectively remove autoantibodies from body fluids. This technology has significant implications for improving patient care in autoimmune diseases.

Latest Patents

Ryuichi Yokohari holds a patent for an invention titled "Autoantibody Adsorbent And Apparatus For Removing Autoantibodies Using The Same." The abstract of the disclosure describes an adsorbent that combines an autoantibody with its homologous antigen. This adsorbent comprises a water-insoluble porous material and a compound with an anionic functional group immobilized onto the material. The apparatus allows for the selective removal of autoantibodies or immune complexes from body fluids without eliminating useful components.

Career Highlights

Yokohari is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, where he has been instrumental in advancing research and development in medical technologies. His work has contributed to the understanding and treatment of autoimmune conditions, showcasing his commitment to improving healthcare solutions.

Collaborations

Throughout his career, Ryuichi Yokohari has collaborated with notable colleagues, including Shinichi Aotsuka and Makiko Kinoshita. These partnerships have fostered innovation and have been essential in the development of his patented technologies.

Conclusion

Ryuichi Yokohari's contributions to the field of autoantibody removal technology highlight his role as an innovator in medical science. His work not only advances the understanding of autoimmune diseases but also enhances treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…